Cargando…
Ustekinumab trough levels predicting laboratory and endoscopic remission in patients with Crohn’s disease
BACKGROUNDS: Optimal concentration of ustekinumab (UST) predicting endoscopic remission has not been fully investigated in Crohn’s disease (CD). We aimed to identify the optimal UST trough levels predicting clinical, laboratory and endoscopic remission in CD patients. METHODS: Twenty-eight patients...
Autores principales: | Hirayama, Hisashi, Morita, Yasuhiro, Imai, Takayuki, Takahashi, Kenichiro, Yoshida, Atsushi, Bamba, Shigeki, Inatomi, Osamu, Andoh, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027696/ https://www.ncbi.nlm.nih.gov/pubmed/35448957 http://dx.doi.org/10.1186/s12876-022-02271-4 |
Ejemplares similares
-
Relationship between the gut microbiota and bile acid composition in the ileal mucosa of Crohn’s disease
por: Bamba, Shigeki, et al.
Publicado: (2022) -
Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn’s disease
por: Bamba, Shigeki, et al.
Publicado: (2017) -
Prototype single-balloon enteroscopy with passive bending and high force transmission improves depth of insertion in the small intestine
por: Morita, Yasuhiro, et al.
Publicado: (2020) -
Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn’s Disease
por: Straatmijer, Tessa, et al.
Publicado: (2023) -
Dexmedetomidine is safe and reduces the additional dose of midazolam for sedation during endoscopic retrograde cholangiopancreatography in very elderly patients
por: Inatomi, Osamu, et al.
Publicado: (2018)